Propionitrile

Propionitrile

SCHEMBL10163105

[2H]C([2H])(C)C#N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionitrile SCHEMBL10189197 0.82
SCHEMBL30978756 0.72
Propionitrile SCHEMBL27701221 0.70
Propionitrile SCHEMBL2872825 0.70
Propionitrile SCHEMBL15485 0.70
Propionitrile SCHEMBL28117218 0.70
Propionitrile SCHEMBL10885255 0.67
Propionitrile SCHEMBL6900957 0.67
Propionitrile SCHEMBL11133901 0.67
Propionitrile SCHEMBL7745947 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130274299-A1 Cognition Enhancing Compounds and Compositions, Methods of Making, and Methods of Treating MAPLIGHT THERAPEUTICS, INC. 2013-10-17 US disclosed
US-20120046273-A1 COMPOUNDS AND COMPOSITIONS FOR COGNITION-ENHANCEMENT, METHODS OF MAKING, AND METHODS OF TREATING MITHRIDION, INC. (US) 2012-02-23 US disclosed
US-20110263613-A1 COMPOUNDS AND COMPOSITIONS FOR COGNITION-ENHANCEMENT, METHODS OF MAKING, AND METHODS OF TREATING MAPLIGHT THERAPEUTICS, INC. 2011-10-27 US disclosed
US-20090062323-A1 DEUTERIUM-ENRICHED IRINOTECAN PROTIA, LLC (US) 2009-03-05 US disclosed